Rockwell Medical, Inc. develops and sells biopharmaceutical products that cater to patients with chronic kidney disease and end-stage renal disease. The company provides treatment therapies for iron deficiency, such as Triferic Dialysate and Triferic AVNU, which helps in maintaining hemoglobin levels in dialysis patients. Rockwell Medical, Inc. manufactures and distributes hemodialysis concentrates, ancillary supplies, and is also expanding its product line to include treatments for acute heart failure and infusion therapy.